You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 43 No. 10, October 1986 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Prostaglandin Receptor Sensitivity in Psychiatric Disorders

Philip D. Kanof, MD, PhD; Celeste Johns, MD; Michael Davidson, MD; Larry J. Siever, MD; Emil F. Coccaro, MD; Kenneth L. Davis, MD

Arch Gen Psychiatry. 1986;43(10):987-993.


Abstract

• The cyclic adenosine monophosphate (cAMP) responses to prostaglandin E1 (PGE,) in platelets and leukocytes from drug-free schizophrenic patients, depressive patients, and normal controls have been compared. Both schizophrenic and depressive patients had a significantly lower platelet cAMP response to PGE1 than controls. The platelet cAMP response to PGE, did not discriminate among exacerbated, remitted, and poor-prognosis schizophrenic patients, or between exacerbated and remitted depressive patients. The cAMP response to PGE1 was negatively correlated with global symptom severity in actively ill schizophrenic patients, but was not correlated with symptom severity in exacerbated depressive patients. The leukocyte cAMP response to PGE1 did not differ among normal controls, schizophrenic patients, and depressive patients. These data indicate that a diminished platelet cAMP response to PGE1 may be a marker common to both schizophrenia and depression but that this effect does not extend to a cAMP-linked PGE1 receptor on another blood cell type.



Author Affiliations

From the Departments of Psychiatry (Drs Kanof, Johns, Davidson, Siever, Coccaro, and Davis) and Pharmacology (Dr Davis), Mount Sinai School of Medicine, New York; and the Veterans Administration Medical Center, Bronx, NY (Drs Kanof, Johns, Davidson, Siever, Coccaro, and Davis).


Footnotes

Accepted for publication April 23, 1986.

Reprint requests to Veterans Administration Medical Center, Psychiatry Service (116A), 130 W Kingsbridge Rd, Bronx, NY 10468 (Dr Kanof).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Mechanisms of Action of Lithium: II. Effects on Adenylate Cyclase Activity and {beta}-Adrenergic Receptor Binding in Normal Subjects
Risby et al.
Arch Gen Psychiatry 1991;48:513-524.
ABSTRACT  

{alpha}2-Adrenoceptor--Mediated Inhibition of Platelet Adenylate Cyclase and Induction of Aggregation in Major Depression: Effect of Long-term Cyclic Antidepressant Drug Treatment
Garcia-Sevilla et al.
Arch Gen Psychiatry 1990;47:125-132.
ABSTRACT  

Blunted {beta}-Adrenergic Responsivity of Peripheral Blood Mononuclear Cells in Endogenous Depression: Isoproterenol Dose--Response Studies
Halper et al.
Arch Gen Psychiatry 1988;45:241-244.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1986 American Medical Association. All Rights Reserved.